文献速递白血病淋巴瘤

经典BAF复合物调控人T细胞急性淋巴细胞白血病致癌程序

Canonical BAF complex regulates the oncogenic program in human T-cell acute lymphoblastic leukemia.
PubMed 文献 · Blood · 2024-01-01

研究通过全基因组CRISPR筛选发现经典BRG1/BRM相关因子(cBAF)复合物调控人T细胞急性淋巴细胞白血病(T-ALL)细胞对微环境因子CXCL12的迁移反应。机制上cBAF维持染色质可及性使RUNX1结合CXCR4增强子区,抑制cBAF可致RUNX1从基因组脱落、CXCR4下调及迁移受损,并负向影响增殖、诱导凋亡;T-ALL异种移植模型证实该抗癌效应。

要点

  • cBAF复合物调控T-ALL细胞对CXCL12的迁移反应
  • cBAF维持染色质可及性使RUNX1结合CXCR4增强子区
  • 抑制cBAF可下调CXCR4、损害迁移并诱导凋亡,异种移植模型证实抗癌效应

核心结论

  • cBAF调控RUNX1驱动的白血病程序,并控制人T-ALL向CXCL12的迁移活性和细胞自主性生长。
  • cBAF抑制对增殖产生负面影响并深刻诱导凋亡,提示cBAF为有前景的治疗靶点。

研究设计与样本

  • 研究采用全基因组CRISPR筛选,并利用人T-ALL细胞及T-ALL异种移植模型进行验证。

主要发现

  • 全基因组CRISPR筛选发现cBAF调控人T-ALL细胞对微环境因子CXCL12的迁移反应。
  • cBAF维持染色质可及性并使RUNX1结合至CXCR4增强子区域。
  • 抑制cBAF使RUNX1从基因组脱落,导致CXCR4下调及迁移活性受损。
  • cBAF优先在RUNX1结合位点维持染色质可及性,确保RUNX1在这些位点的结合,并为RUNX1调控基因(如CDK6)的表达所必需。
  • 抑制cBAF对细胞增殖产生负面影响并深刻诱导凋亡;T-ALL异种移植模型证实该抗癌效应。

临床怎么用

  • 原文结论提示cBAF为有前景的治疗靶点。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Acute leukemia cells require bone marrow microenvironments, known as niches, which provide leukemic cells with niche factors that are essential for leukemic cell survival and/or proliferation. However, it remains unclear how the dynamics of the leukemic cell-niche interaction are regulated. Using a genome-wide CRISPR screen, we discovered that canonical BRG1/BRM-associated factor (cBAF), a variant of the switch/sucrose nonfermenting chromatin remodeling complex, regulates the migratory response of human T-cell acute lymphoblastic leukemia (T-ALL) cells to a niche factor CXCL12. Mechanistically, cBAF maintains chromatin accessibility and allows RUNX1 to bind to CXCR4 enhancer regions. cBAF inhibition evicts RUNX1 from the genome, resulting in CXCR4 downregulation and impaired migration activity. In addition, cBAF maintains chromatin accessibility preferentially at RUNX1 binding sites, ensuring RUNX1 binding at these sites, and is required for expression of RUNX1-regulated genes, such as CDK6; therefore, cBAF inhibition negatively impacts cell proliferation and profoundly induces apoptosis. This anticancer effect was also confirmed using T-ALL xenograft models, suggesting cBAF as a promising therapeutic target. Thus, we provide novel evidence that cBAF regulates the RUNX1-driven leukemic program and governs migration activity toward CXCL12 and cell-autonomous growth in human T-ALL.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Aoki K, Hyuga M, Tarumoto Y, et al. Canonical BAF complex regulates the oncogenic program in human T-cell acute lymphoblastic leukemia. Blood. 2024. PMID: 37922452. doi:10.1182/blood.2023020857

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。